Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum VALEANT PHARMACEUTICALS INTL INC T.VRX

Healthcare Drug Manufacturers - Specialty & Generic
"Valeant Pharmaceuticals is a global specialty pharmaceutical firm with a focus on branded products for the dermatology, gastrointestinal, and ophthalmology markets. The firm also has a branded generics business that operates primarily in Latin America, Eastern Europe, and Asia."

TSX:VRX - Post Discussion

VALEANT PHARMACEUTICALS INTL INC > Knight therapeutics
View:
Post by deeppocket83 on Dec 04, 2016 10:57pm

Knight therapeutics

Looking to purchase Valeants Canadian business.
Comment by biggerr on Dec 05, 2016 12:50am
they just spread these rumors to lure suckers to buy VRX like it was a month ago with Takeda, only buy when there is an actual sale
Comment by deeppocket83 on Dec 05, 2016 9:07am
Thats not the point. The point is  there is lot more interest for Valeant and its assets then meets the eye. Funny thing is not a single article or neither an analyst on CNBC is mentioning what they have in the pipline for revenue growth. They have close to another 1billion in revenue of growth in the Pipe. What we have today is a much better company then 6 months ago and we are trading 50 ...more  
Comment by biggerr on Dec 05, 2016 10:15am
it's than 6 months ago, not then 6 months ago - other THAN that I agree with you, ha
Comment by deeppocket83 on Dec 05, 2016 10:27am
lol thanks for the grammer check! 
VALEANT PHARMACEUTICALS INTL INC
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities